The Burrill Report

The Burrill Report (August 1, 2011): Getting the Prevent Defense to Pay Off (.MP3,11.53 Mb)

Prevention has long been touted as a key to bringing the rising costs of healthcare under control, but makers of diagnostics that promise to deliver early warnings of developing disease face challenges with getting doctors to use their tests and payers to reimburse them for the value they provide. Tethys Biosciences, a maker of a predictive test that it says can tell patients their likelihood of developing diabetes within five years, is now armed with a new economic analysis that provides it with a cost-benefits argument for use of its PreDx diagnostic. We spoke to Mickey Urdea, chairman, co-founder and chief scientific officer of the company, about the new study, how the company’s strategy has evolved, and what it will take to incorporate personalized medicine routinely into medical practice.

July 29, 2011
http://www.burrillreport.com/article-getting_the_prevent_defense_to_pay_off.html